Latest News From "The Pink Sheet" DAILY - PhRMA Helps Roll-Out New Health Reform Ad Campaign

Russell Greig Leaves GSK's SR One

The managing partner and president of GSK's corporate venture group appears to have quietly moved on.   read more

 

PhRMA Backs New Health Reform Ads Targeting Key House Democrats

PhRMA helps to roll-out a new ad campaign that stresses the health care reform is at its finish line, just as the association convenes in D.C. for its annual meeting.   read more

 

Unigene Restructures Its Debt, Bringing In $13.6 Million In Cash

The osteoporosis firm's lame-duck CEO and two other top executives will step down under revised financing.   read more

 

Merck And Teva Settle Temodar Patent Suit, But Appeals Case Continues

Teva will launch its generic only if an appeals court finds the Temodar patent is unenforceable; otherwise it can do so six months before the patent expires.   read more

 

PTO Must Reconsider Medicines Co.'s Request For Angiomax Patent Extension

A federal court vacated the patent office's denial of The Medicines Company's application for patent term extension, saying it should reconsider the date of Angiomax approval.   read more

 

Sucampo Seeks To Terminate Amitiza Marketing Agreement With Takeda

Sucampo Pharmaceuticals requests arbitration to end its partnership with Takeda, claiming the company has failed to maximize sales of the constipation drug Amitiza.   read more

 

Hatch Flips Focus To NDI Guidance In McCain Steroid Bill Negotiations

Sens. McCain and Dorgan float requiring FDA to publish an NDI notification guidance under food safety bill, in a turnaround Sen. Hatch prompted.   read more

 

"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here